-transparent.png){kind=logo}
To determine the effects of anti-T cell monoclonal antibody-induced systemic T cell depletion in neuro-autoimmune disease, we studied the in vivo effects of 8BE6, a mouse anti-guinea pig (GP) pan-T cell monoclonal antibody, on the course and immunopathology of the disease model experimental allergic encephalomyelitis (EAE) in adult Strain 13 GP. Central nervous system (CNS) tissues were studied by routine histology and by an immunoperoxidase staining technique using monoclonal antibodies to T cells, IgM, and macrophages. From 3 days before to 10 days after sensitization with GP spinal cord and complete Freund's adjuvant, the GP were given one or two i.p. doses of 3.4 mg 8BE6 or MOPC 21, the parent mouse myeloma ascites, or normal saline. Eighteen of 18 control-treated GP developed typical acute, paralytic EAE 11 to 21 days after sensitization, whereas acute EAE was prevented in 33 of 49 8BE6-treated GP (67%), and the onset was delayed and disease progression was slowed in the others. Five GP treated with 8BE6 from days 11 to 14 after sensitization, at the onset of neurologic signs, rapidly deteriorated within hours after treatment and had loss of T cell staining, and lymphocytolysis in the CNS. 8BE6-treated GP which did not develop acute EAE were observed daily for up to 700 days (mean = 213 days). Twenty-nine of 39 (74%) had from one to six relapses or fixed neurologic deficits. GP in relapse were additionally treated with 8BE6 (22), MOPC-21 (5), or saline (6) in a cross-over protocol. Clinical scores were improved from days 2 to 12 after treatment (p less than 0.05), and complete recovery within 30 days occurred more frequently (p = 0.046) and more rapidly (p less than 0.01), after 8BE6 as compared with control treatments. Recoveries occurred more often if 8BE6 was given early in the relapse. Multiple treatments led to dose-dependent levels of serum antibodies to mouse immunoglobulin detected by an ELISA. There were no differences between acute and chronic EAE in numbers of inflammatory foci or numbers of macrophages and T cells in CNS infiltrates, but GP with chronic EAE had more extensive demyelination and vascular fibrosis and more numerous IgM+ B cells in parenchymal and meningeal infiltrates than in acute EAE (p less than 0.001).(ABSTRACT TRUNCATED AT 400 WORDS)
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
May 1983,
Journal of neuropathology and experimental neurology,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
May 1987,
Clinical and experimental immunology,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
January 1985,
Journal of neuroimmunology,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
October 1980,
Rinsho shinkeigaku = Clinical neurology,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
January 1984,
Progress in clinical and biological research,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
February 1993,
Journal of immunology (Baltimore, Md. : 1950),
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
February 1981,
The Japanese journal of experimental medicine,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
June 1980,
The Japanese journal of experimental medicine,
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
November 1988,
Journal of immunology (Baltimore, Md. : 1950),
R A Sobel, and
B W Blanchette, and
M A Russo, and
A M Williams, and
R B Colvin
February 1988,
Journal of the neurological sciences,
